Biomarkers for Prediabetes, Type 2 Diabetes, and Associated Complications

Purpose: Diabetes mellitus is a chronic disorder caused by high blood glucose levels due to insulin resistance or insufficient insulin production in pancreatic β-cells. Due to its fastest-growing public health concerns worldwide, it is important to evaluate metabolic profile abnormalities before pre-diabetes or T2DM to anticipate and prevent disease progression. The purpose of the study was to examine the metabolite biomarkers by systematic review and meta-analysis to support early detection of pre-diabetes and T2DM. Methodology: Studies published from the earliest online through May 31, 2023, were searched in the Cochrane Library, EMBASE, PubMed, and Scopus. Article titles, abstracts, and complete texts were reviewed after duplicate records were eliminated. Two writers (Long and Yang) created the following inclusion criteria for the publications before literature screening: The study was conducted on humans, did not involve gestational diabetes mellitus (GDM), type 1 diabetes mellitus (T1DM), or subjects under 18 years old, included a diabetic or prediabetes group, and followed international diagnostic guidelines (American Diabetes Association, 2013). Findings: The study aimed to review the biomarkers that have been utilized for diabetes in previous research. The comparison of the biomarkers mentioned in the provided information revealed a complex interplay of factors influencing the risk and management of Type 2 Diabetes (T2D). These biomarkers encompass genetic, lifestyle, environmental, and insulin-related factors, each with varying degrees of accuracy and specificity in predicting T2D risk or guiding its management. Recommendations: The research will help in spreading awareness among people regarding the identification of diabetes as understanding biomarker-based screening's economic impact can inform healthcare policies. Future studies should validate these biomarkers' diagnostic capacities across varied populations and circumstances. Assessment of these biomarkers' predictive usefulness should be done over time via longitudinal research. Understanding biomarker alterations and diabetes progression improves risk prediction.

• Publication year

  2023

• Venue

  American journal of health, medicine and nursing practice

• Publication date

  2023-09-27

• Fields of study

  Not labeled

• Identifiers
  DOI 10.47672/ajhmn.1592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.

  2021influential reference
• Hyperinsulinemia Drives Epithelial Tumorigenesis by Abrogating Cell Competition.

  2020cited by this paper
• Association Between Genetic Risk and Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study.

  2019cited by this paper
• Improving obesity and blood pressure

  2019cited by this paper
• Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

  2018cited by this paper
• Genomic insights into the causes of type 2 diabetes.

  2018cited by this paper
• Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses

  2018cited by this paper
• IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

  2018influential reference
• The value of genetic risk scores in precision medicine for diabetes

  2018cited by this paper
• The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases

  2017cited by this paper
• Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients

  2017cited by this paper
• Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study

  2017cited by this paper
• 10 Years of GWAS Discovery: Biology, Function, and Translation.

  2017cited by this paper
• Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance.

  2017cited by this paper
• Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function

  2017cited by this paper
• Mini robotic gastric bypass surgery

  2016cited by this paper
• Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia – 1,5‐anhydroglucitol, fructosamine, and glycated albumin

  2016cited by this paper
• Short Adult Stature Predicts Impaired &bgr;-Cell Function, Insulin Resistance, Glycemia, and Type 2 Diabetes in Finnish Men

  2016cited by this paper
• Hyperinsulinemia augments endothelin‐1 protein expression and impairs vasodilation of human skeletal muscle arterioles

  2016cited by this paper
• Genetic-risk assessment of GWAS-derived susceptibility loci for type 2 diabetes in a 10 year follow-up of a population-based cohort study

  2016cited by this paper
• HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions.

  2015cited by this paper
• Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers

  2015cited by this paper
• Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes

  2015cited by this paper
• Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol

  2015influential reference
• Prediabetes diagnosis and treatment: A review.

  2015influential reference
• A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study

  2015cited by this paper
• Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

  2014influential reference
• Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort

  2014cited by this paper
• Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity

  2014cited by this paper
• Use of HbA1c for Diagnoses of Diabetes and Prediabetes: Comparison with Diagnoses Based on Fasting and 2-Hr Glucose Values and Effects of Gender, Race, and Age

  2014cited by this paper
• Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study

  2014cited by this paper
• Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading

  2013influential reference
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: a systematic review.

  2013cited by this paper
• Genetic Screening for the Risk of Type 2 Diabetes

  2013cited by this paper
• No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population

  2011cited by this paper
• IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

  2011cited by this paper
• IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• [Type-2 diabetes].

  2010cited by this paper
• Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.

  2010cited by this paper

• Physicochemical, functional, antioxidant and anti-diabetic properties of rice, chickpea and lentil flour grown in Kashmir Valley of India

  2025cites this paper
• The Critical Role of Biochemical Markers in the Early Diagnosis of Chronic Diseases

  2025cites this paper
• Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)

  2024cites this paper
• Significance of fostering the mental health of patients with diabetes through critical time intervention

  2023cites this paper